Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Interleukin signs new research agreement with Alticor
Under the terms of the agreement, ABG will pay Interleukin Genetics $1.2 million during 2008 for the research. Approximately $800,000 of unspent funding from prior research agreements with
Under the terms of the agreement, ABG will pay Interleukin Genetics $1.2 million during 2008 for the research. Approximately $800,000 of unspent funding from prior research agreements with
The main objective of the ATP regulation is to centralize the regulatory and scientific requirements and to help small and medium-sized enterprises gain access to all EU markets.
Vitivia’s first product introduction will be its Pro:Vitamin line that combines pure concentrations of natural ingredients with the best of modern science. Jonathan Alba, COO of JSJ, said:
Under the terms of the collaboration the three parties are engaged in a drug discovery research program, with Genentech and Abbott being responsible for the development, manufacturing and
In this randomized, controlled Phase I trial, 72 individuals received one shot of either Agrippal, or Agrippal combined with one of two different concentrations of IC31. All study
Microcyn demonstrated a positive clinical response, defined as the clinical cure or improvement of infection, as a monotherapy and in combination with levofloxacin, a systemic antibiotic. No serious
The committee stopped the trial of more than 400 patients conducted in 12 countries because the study met its primary endpoint. Safety findings in the study were manageable
These generic torsemide tablets are therapeutic equivalents of Roche’s Demadex tablets and include four strengths: 5mg, 10mg, 20mg and 100mg. Torsemide is a diuretic, indicated for the treatment
The Mayfield system is designed to maintain the stability of a patient’s head during brain surgery. The Mayfield skull pins have received FDA clearance in the US, as
The novel drug is a small molecule named cis-ACCP, which is a prototype of a family of compounds that may be administered orally and was shown to be